Author

Salah Boudjadi

National Cancer InstituteORCID 0000-0002-0273-8696Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Abbas Yousefi-Rad· 1 shared Abdul Rouf BandayiD· 1 shared Andrea Borghese ApoloiD· 1 shared Arup Chakraborty· 1 shared Ayşe Gökçe KeşküşiD· 1 shared Benjamin Z. StantoniD· 1 shared Bilal A. Lone· 1 shared Dhanusha YesudhasiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abbas Yousefi-Rad

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyMolecular Cancer ResearchPeer-reviewedAug 17, 2026

MIR17HG Expression Is Transcriptionally Regulated by PAX3::FOXO1 and MYCN 1 and is Necessary for Oncogenic Activity in Fusion-Positive Rhabdomyosarcoma

Shabir Zargar, Pawan Kumar Raut, Hana Kim…·Frederic G. Barr

This study identifies PAX3::FOXO1 and MYCN as cooperative regulators of MIR17HG expression in fusion-positive rhabdomyosarcoma and shows miR-17-92 is necessary for oncogenic activity.

DOI 10.1158/1541-7786.mcr-26-0074

humangenetic perturbation / CRISPR

Cancer BiologybioRxivPreprintJul 4, 2026

APOBEC3-driven neoantigen-rich cancers co-opt 1q23.3 amplification for tumor-intrinsic immune cloaking

Dhanusha Yesudhas, Bilal A. Lone, Ecem Ünal…·Abdul Rouf Banday

The paper identifies a tumor-intrinsic immune-cloaking mechanism in neoantigen-rich cancers driven by APOBEC3 mutagenesis and 1q23.3 amplification, showing NECTIN4's role in suppressing immune responses.

DOI 10.64898/2026.07.01.735125

humanbulk RNA-seq